309 related articles for article (PubMed ID: 21087503)
1. Hypercholesterolemia and microvascular dysfunction: interventional strategies.
Stapleton PA; Goodwill AG; James ME; Brock RW; Frisbee JC
J Inflamm (Lond); 2010 Nov; 7():54. PubMed ID: 21087503
[TBL] [Abstract][Full Text] [Related]
2. Keep recycling going: New approaches to reduce LDL-C.
Klein-Szanto AJP; Bassi DE
Biochem Pharmacol; 2019 Jun; 164():336-341. PubMed ID: 30953636
[TBL] [Abstract][Full Text] [Related]
3. Endothelial dysfunction in human disease.
Drexler H; Hornig B
J Mol Cell Cardiol; 1999 Jan; 31(1):51-60. PubMed ID: 10072715
[TBL] [Abstract][Full Text] [Related]
4. Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide.
Stokes KY; Cooper D; Tailor A; Granger DN
Free Radic Biol Med; 2002 Oct; 33(8):1026-36. PubMed ID: 12374614
[TBL] [Abstract][Full Text] [Related]
5. Impact of chronic anticholesterol therapy on development of microvascular rarefaction in the metabolic syndrome.
Goodwill AG; Frisbee SJ; Stapleton PA; James ME; Frisbee JC
Microcirculation; 2009 Nov; 16(8):667-84. PubMed ID: 19905967
[TBL] [Abstract][Full Text] [Related]
6. Maternal hypercholesterolemia in pregnancy associates with umbilical vein endothelial dysfunction: role of endothelial nitric oxide synthase and arginase II.
Leiva A; de Medina CD; Salsoso R; Sáez T; San Martín S; Abarzúa F; Farías M; Guzmán-Gutiérrez E; Pardo F; Sobrevia L
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2444-53. PubMed ID: 23950140
[TBL] [Abstract][Full Text] [Related]
7. Dyslipidemias and Microcirculation.
Padró T; Vilahur G; Badimon L
Curr Pharm Des; 2018; 24(25):2921-2926. PubMed ID: 29968532
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein Apheresis Acutely Reverses Coronary Microvascular Dysfunction in Patients With Severe Hypercholesterolemia.
Wu MD; Moccetti F; Brown E; Davidson BP; Atkinson T; Belcik JT; Giraud G; Duell PB; Fazio S; Tavori H; Tsimikas S; Lindner JR
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 1):1430-1440. PubMed ID: 29909101
[TBL] [Abstract][Full Text] [Related]
9. Hypercholesterolemia promotes a CD36-dependent and endothelial nitric-oxide synthase-mediated vascular dysfunction.
Kincer JF; Uittenbogaard A; Dressman J; Guerin TM; Febbraio M; Guo L; Smart EJ
J Biol Chem; 2002 Jun; 277(26):23525-33. PubMed ID: 11976335
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.
Woodman RJ; Chew GT; Watts GF
Drugs; 2005; 65(1):31-74. PubMed ID: 15610050
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide therapies in vascular diseases.
Kurowska EM
Curr Pharm Des; 2002; 8(3):155-66. PubMed ID: 11812265
[TBL] [Abstract][Full Text] [Related]
12. Microvascular reactivity in patients with hypercholesterolemia: effect of lipid lowering treatment.
Stulc T; Kasalová Z; Prázný M; Vrablík M; Skrha J; Ceska R
Physiol Res; 2003; 52(4):439-45. PubMed ID: 12899656
[TBL] [Abstract][Full Text] [Related]
13. Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences.
John S; Schmieder RE
J Hypertens; 2000 Apr; 18(4):363-74. PubMed ID: 10779084
[TBL] [Abstract][Full Text] [Related]
14. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.
Sahebkar A; Watts GF
Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550
[TBL] [Abstract][Full Text] [Related]
15. Selective loss of microvascular endothelial function in human hypercholesterolemia.
Gilligan DM; Guetta V; Panza JA; García CE; Quyyumi AA; Cannon RO
Circulation; 1994 Jul; 90(1):35-41. PubMed ID: 8026018
[TBL] [Abstract][Full Text] [Related]
16. Effects of L-arginine on the endogenous angiogenic response in a model of hypercholesterolemia.
Nakai Y; Voisine P; Bianchi C; Xu SH; Feng J; Malik T; Rosinberg A; Sellke FW
Surgery; 2005 Aug; 138(2):291-8. PubMed ID: 16153439
[TBL] [Abstract][Full Text] [Related]
17. Coronary endothelial dysfunction induced by nucleotide oligomerization domain-like receptor protein with pyrin domain containing 3 inflammasome activation during hypercholesterolemia: beyond inflammation.
Zhang Y; Li X; Pitzer AL; Chen Y; Wang L; Li PL
Antioxid Redox Signal; 2015 May; 22(13):1084-96. PubMed ID: 25739025
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin increases myocardial indices of oxidative stress in a porcine model of hypercholesterolemia and chronic ischemia.
Sodha NR; Boodhwani M; Ramlawi B; Clements RT; Mieno S; Feng J; Xu SH; Bianchi C; Sellke FW
J Card Surg; 2008; 23(4):312-20. PubMed ID: 18598320
[TBL] [Abstract][Full Text] [Related]
19. Association between isolated hypercholesterolemia, isolated hypertriglyceridemia and coronary artery disease in south Indian type 2 diabetic patients.
Rajmohan L; Deepa R; Mohan A; Mohan V
Indian Heart J; 2000; 52(4):400-6. PubMed ID: 11084779
[TBL] [Abstract][Full Text] [Related]
20. Retinal microvascular dysfunction in hypercholesterolemia.
Nägele MP; Barthelmes J; Ludovici V; Cantatore S; Frank M; Ruschitzka F; Flammer AJ; Sudano I
J Clin Lipidol; 2018; 12(6):1523-1531.e2. PubMed ID: 30219640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
